Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Empty Capsules Market: USD 4.2B by 2029, 6.3% CAGR, Driven by Nutraceuticals & Pharmaceuticals | MarketsandMarkets™


News provided by

MarketsandMarkets

21 Jun, 2024, 14:15 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, June 21, 2024 /PRNewswire/ -- The global empty capsules market is projected to reach USD 4.2 billion by 2029, expanding from USD 3.1 billion in 2024, driven by growing demand for nutraceuticals, pharmaceutical advancements, and increased clinical trials and R&D activities. Major players such as Capsugel (Lonza), ACG, and QUALICAPS are implementing diverse strategies such as new product introductions, acquisitions, and global expansions to bolster their market positions. Capsugel (Lonza) leads with innovations like their recent acid-sensitive capsule launch, while ACG enhances production capacity with significant investments in sustainable manufacturing. QUALICAPS maintains a strong global presence and high-quality standards through strategic production facilities, supporting their role in therapeutic applications including antibiotics, dietary supplements, antacids, and cardiovascular drugs.

This image opens in the lightbox
MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190

Browse in-depth TOC on "Empty Capsules Market"

356 - Tables
48 - Figures
333 - Pages

Empty Capsules Market Report Highlights:

  • Updated market size from 2023 with forecasts till 2029, considering recession impacts.
  • Volume data on gelatin and non-gelatin capsules across regions.
  • Enhanced market overview includes supply chain analysis, upcoming events (2024-25), and investment scenarios.
  • Expanded geographic coverage: South Korea added in Asia Pacific; Latin America segmented into Brazil, Mexico, and rest; Middle East and Africa provided separately.
  • Updated recession impact analysis by region.
  • Latest competitive landscape: market strategies, share analysis, and leadership mapping.
  • Comprehensive updates on market evaluation, revenue analysis, and company profiles for top 23 firms and 8 SMEs/startups.
  • Financial insights till 2023, graphical representation for easy analysis.
  • Detailed market share and revenue analysis for 2023, competitive benchmarking, and growth strategies.
  • Additional profiles of 31 companies, reflecting recent market developments (2021-2024) and product launches.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190

Market Projection and Growth Drivers

The empty capsules market is projected to grow from USD 3.1 billion in 2024 to USD 4.2 billion by 2029, at a CAGR of 6.3%. This growth is driven by advancements in capsule delivery technologies, increased focus on pharmaceutical development, and a rising number of clinical trials, enhancing the market's expansion prospects.

Technological Advancements Driving Demand

Advancements in capsule delivery technology, including targeted delivery, controlled release mechanisms, and enhanced bioavailability, are propelling the demand for empty capsules. These innovations support more effective drug formulations, cater to expanding pharmaceutical and nutraceutical sectors, and align with trends in personalized medicine, thereby boosting market growth.

Market Segmentation by Type and Functionality

The empty capsules market is segmented into gelatin capsules (including porcine, bovine, bone meal, and other sources) and non-gelatin capsules (such as HPMC and pullulan/starch capsules). Gelatin capsules dominate due to superior bioavailability, ease of swallowing, and compatibility with various active ingredients. Functionally, the market comprises immediate-release, sustained-release, and delayed-release capsules, with immediate-release capsules leading in 2023 for their ease of use and broad formulation applicability.

Therapeutic Applications and End-User Segments

Therapeutic applications include antibiotic & antibacterial drugs, dietary supplements, antacids, antianemics, anti-inflammatories, cardiovascular therapies, and more. Antibiotic & antibacterial drugs led the market in 2023 due to increasing bacterial infections and demand for effective treatments. The pharmaceutical industry is the largest end-user segment, leveraging empty capsules for diverse drug formulations and improving patient compliance through easy administration.

Regional Market Insights

North America held the largest share of the market in 2023, driven by robust pharmaceutical and nutraceutical industries, demand for advanced drug delivery systems, and consumer preference for dietary supplements. However, Asia Pacific is expected to be the fastest-growing market during the forecast period, fueled by expanding healthcare expenditure, a burgeoning pharmaceutical sector, and rising chronic disease prevalence, alongside increasing awareness of health and wellness.

Recent Developments:

1.  Roquette completed the acquisition of Qualicaps in October 2023, expanding its global presence and enhancing its oral dosage solutions portfolio. This strategic move combines Roquette's and Qualicaps' capabilities to offer a wider range of innovative capsules and pharmaceutical solutions, bolstering technical expertise and customer service.

2.  Lonza introduced Capsugel Enprotect in November 2022, a coating-free capsule designed for efficient intestinal drug delivery. This breakthrough technology targets various therapeutics, including small molecules, peptides, proteins, and RNA-based drugs, as well as live biotherapeutic products.

3.  ACG signed a Memorandum of Understanding with the Maharashtra government in December 2021 to establish Asia's largest capsule manufacturing facility in Aurangabad. Expected to produce 40 billion capsules annually, this plant will cater to both domestic and global pharmaceutical and nutraceutical markets.

For more information, inquire now! Inquire Now

Related Reports:

Pharmaceutical Excipients Market

Active Pharmaceutical Ingredient Market

Softgel Capsules Market

Pharmaceutical Gelatin Market

High Potency APIs Market

Get access to the latest updates on Empty Capsules Companies and Empty Capsules Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025

360Quadrants has released its latest PFAS testing Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and ...

Healthcare Simulation Market worth US$7.23 billion by 2030 with 15.6% CAGR | MarketsandMarkets™

Healthcare Simulation Market worth US$7.23 billion by 2030 with 15.6% CAGR | MarketsandMarkets™

The global Healthcare Simulation Market, valued at US$3.00 billion in 2024 stood at US$3.50 billion in 2025 and is projected to advance at a...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.